The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) P/S ratio
As of 5 November 2026, The Chemours Company (CC) trades at a P/S ratio of 0.3×. Over the past ten years it has ranged from 0.0× (June 2015) to 1.8× (October 2017); the current reading is higher than 15% of that period. That is below the Specialty Chemicals industry median of 1.6× and below the Basic Materials sector median of 1.6×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.3× | (30.21%) |
| FY2024 | 0.4× | (43.87%) |
| FY2023 | 0.8× | 11.80% |
| FY2022 | 0.7× | (20.17%) |
| FY2021 | 0.9× | 6.18% |
| FY2020 | 0.8× | 52.29% |
| FY2019 | 0.5× | (28.29%) |
| FY2018 | 0.8× | (51.36%) |
| FY2017 | 1.5× | 116.73% |
| FY2016 | 0.7× | 320.57% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 0.4× | (34.34%) |
| Jun 2026 | 0.5× | (6.19%) |
| Mar 2026 | 0.6× | 87.08% |
| Dec 2025 | 0.3× | (25.25%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| STDN Standard Nuclear Inc compare | n/m |
| CC The Chemours Company | 0.3× |
| SCL Stepan Company compare | 0.6× |
| FUL H. B. Fuller Company compare | 0.8× |
| MTX Minerals Technologies Inc. compare | 0.9× |
| IOSP Innospec Inc. compare | 1.0× |
| KWR Quaker Houghton compare | 1.3× |
| NGVT Ingevity Corporation compare | 1.9× |
| WDFC WD-40 Company compare | 4.4× |
| Specialty Chemicals industry median | 1.6× |
| Basic Materials sector median | 1.6× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement